| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 87 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Brown Michael S49 | Director | Sale+OE | 1,172 | $974.86 | $1,142,535.92 | -45.9% | +23.2% | -39.2% | |
| May 21, 2024 | Larosa Joseph J66 | EVP General Counsel And Secret | Sell | 1,865 | $994.90 | $1,855,488.50 | -5.1% | +20.4% | -39.2% | |
| May 17, 2024 | Schleifer Leonard S64 | Bd. Co-chair, President &CEO | Sell | 22,830 | $979.23 | $22,355,714.15 | -2.4% | +19.7% | -39.5% | |
| May 16, 2024 | Yancopoulos George50 | Bd. Co-chair, President &CSO | Sell | 50,000 | $972.73 | $48,636,545.34 | -0.5% | +19.5% | -38.6% | |
| May 15, 2024 | Yancopoulos George50 | Bd. Co-chair, President &CSO | Sell | 50,000 | $975.87 | $48,793,727.12 | -0.2% | +18.4% | -40.2% | |
| May 15, 2024 | Schleifer Leonard S64 | Bd. Co-chair, President &CEO | Sale+OE | 35,941 | $979.58 | $35,207,110.13 | -0.7% | +18.4% | -40.2% | |
| May 1, 2024 | McCourt Marion55 | EVP Commercial | Sell | 250 | $889.41 | $222,352.50 | -1.9% | +19.3% | -34.7% | |
| May 1, 2024 | Ryan Arthur F54 | Director | Sell | 100 | $899.61 | $89,960.51 | - | +19.3% | -34.7% | |
| Apr 1, 2024 | Ryan Arthur F54 | Director | Sell | 100 | $962.53 | $96,253.25 | - | +9.0% | -36.3% | |
| Apr 1, 2024 | McCourt Marion55 | EVP Commercial | Sell | 250 | $964.73 | $241,182.50 | -1.9% | +9.0% | -36.3% |